FISH
Sponsors
Isfahan University of Medical Sciences, Harvard School of Public Health (HSPH), Nanfang Hospital, Southern Medical University, University of Ulster, Tianjin Medical University Cancer Institute and Hospital
Conditions
Adult Acute Lymphoblastic LeukemiaAdult Lymphoblastic LymphomaCardiovascular Risk Factor and Kidney Related BiomarkersFood allergy
hypersensitiveIodine BioavailabilityLeukemiaLeukemia, AcuteLeukemia, Lymphoblastic
Phase 2
FAST * Food Allergy Specific ImmunoTherapy
A multinational phase IIb study to investigate the efficacy and safety of subcutaneous immunotherapy with a modified fish- parvalbumin given in single rising and maintenance doses to subjects allergic to fish
Active, not recruitingNL-OMON43811
Start: 2016-02-12Target: 10Updated: 2024-02-28
Precision Diagnosis Directing HDACi Chidamide Target Therapy for Adult ETP-ALL
NCT03553238
Start: 2016-02-14End: 2020-08-30Target: 70Updated: 2018-06-12
Precision Diagnosis Directing HDACi Chidamide Target Therapy for Adult T-LBL/ALL
NCT03564704
Start: 2016-02-14End: 2021-05-30Target: 80Updated: 2018-06-21
Unknown Phase
Omega-3 and Cardiovascular Risk Factors and Kidney Related Biomarkers
CompletedNCT03197220
Start: 2015-11-22End: 2017-01-20Updated: 2020-04-07
Fish and Marine Fatty Acids, Genetic Signatures of Diet Adaptation, and Long-term Weight Changes
CompletedNCT03348566
Start: 2015-02-01End: 2016-03-01Updated: 2023-12-19
The Influence of Fish Consumption on Polyunsaturated Fatty Acid (PUFA) Status
CompletedNCT03765580
Start: 2016-09-01End: 2017-05-31Updated: 2018-12-05
The MDA Test to Differentiate of Benign and Malignant Pulmonary Nodules
NCT03790735
Start: 2018-05-03End: 2019-06-30Target: 200Updated: 2019-01-02
Impact of the Food Matrix on Iodine Bioavailability
CompletedNCT04867031
Start: 2017-08-26End: 2018-07-03Updated: 2023-01-10
Retrospective Study of Disease Characteristics and Treatment Response in Patients with Plasma Cell Disorders Classified by Genetic Abnormalities from Fluorescence In Situ Hybridization (FISH)
Active, not recruitingTCTR20251217006
Start: 2026-01-01Target: 156Updated: 2026-03-30